Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Metadata
Title
Complement-mediated renal injury: Mechanisms and role of membrane regulators of complement
Authors
Seiichi Matsuo
Yoshiki Morita
Masashi Mizuno
Kazuhiro Nishikawa
Yukio Yuzawa
Publication date
01-12-1998
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/1998
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/BF02480454

Other articles of this Issue 4/1998

Clinical and Experimental Nephrology 4/1998 Go to the issue

Original Article

Glomerulointerstitial events in rapidly progressive nephritic syndrome, with special reference to histologic grade and stage on the renal lesions

Original Article

Effects of long-term oral magnesium treatment on blood pressure and vascular reacitivity in Dahl salt-sensitive rats

Frontiers of Nephrology

Cell-mediated tubulointerstitial nephritis

Review Article [Oshima Award]

Gene polymorphism and chronic renal diseases

Letter to the Editor

Serum cholesterol level and the rate of progression to renal failure

Frontiers of Nephrology

Chemokines and nephritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits